A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

• Status: Completed
• Trial end date: 2012-11-01

Summary

The purpose of the study is to compare the effects on overall glycaemic control of two insulin intensification therapies.

• Phase: Phase 4

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Biphasic Insulins; Insulin; Insulin Glargine; Insulin Lispro; Insulin, Globin Zinc; Insulin, Isophane; Isophane insulin, insulin lispro drug combination 50:50